Literature DB >> 26278014

Predictors of intrahepatic cholangiocarcinoma in cirrhotic patients scanned by gadobenate dimeglumine-enhanced magnetic resonance imaging: diagnostic accuracy and confidence.

Emilio Quaia1, Roberta Angileri2, Federica Arban2, Antonio Giulio Gennari2, Maria Assunta Cova2.   

Abstract

OBJECTIVE: To identify predictors of intrahepatic cholangiocarcinoma in cirrhotic patients scanned by gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging.
METHODS: Fifty cirrhotic patients with 120 nodules, including 10 mass-forming intrahepatic cholangiocarcinomas and two combined hepatocellular carcinoma-cholangiocarcinomas, were scanned by Gd-BOPTA-enhanced MR imaging.
RESULTS: T1 hypointensity [odds ratio (OR), 20.12], peripheral hyperintense rim at hepatic arterial phase (OR, 13.5), and iso-hyperintensity at hepatobiliary phase (OR 21.32) were found to be independent predictors of intrahepatic cholangiocarcinoma.
CONCLUSIONS: T1 hypointensity, peripheral hyperintense rim at hepatic arterial phase, and iso-hyperintensity at hepatobiliary phase are independent predictors of intrahepatic cholangiocarcinoma diagnosis in patients with liver cirrhosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Fibrosis; Hepatocellular; Logistic models; Magnetic resonance imaging

Mesh:

Substances:

Year:  2015        PMID: 26278014     DOI: 10.1016/j.clinimag.2015.06.013

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  2 in total

1.  DWI Combined With Hepatobiliary-Phase Enhanced Imaging Can Better Differentiate Cholangiocarcinoma From Atypical Liver Abscesses.

Authors:  Li-Hong Xing; Li-Yong Zhuo; Yu Zhang; Xi Ma; Ze-Peng Ma; Ying-Jia Zhao; Xiao-Ping Yin; Bu-Lang Gao
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

2.  Contrast-enhanced multiple-phase imaging features of intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma with cirrhosis: A comparative study.

Authors:  Ying Chen; Yao Pan; Ke-Ren Shen; Xiu-Liang Zhu; Chen-Ying Lu; Qing-Hai Li; Shu-Gao Han; Yan-Biao Fu; Xiu-Fang Xu; Ri-Sheng Yu
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.